Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice

Journal of Gene Medicine

Volumn 5, Issue 11, 2003, Pages 941-950

  Bouchard, Sarah ^a   MacKenzie, Tippi C ^a   Radu, Antoneta P ^a   Hayashi, Satoshi ^a   Peranteau, William H ^a   Chirmule, Narendra ^b   Flake, Alan W ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adeno associated virus; Adenovirus; Fetal therapy; Gene transfer; Muscular dystrophy; Prenatal treatment; Viral vectors

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; NEUTRALIZING ANTIBODY; VIRUS ANTIGEN; VIRUS ANTIBODY;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FETUS; GENE EXPRESSION; GENE TRANSFER; GESTATIONAL AGE; HEART MUSCLE CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MOUSE; MUSCLE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TRANSGENE; ADENOVIRUS; ANIMAL; BAGG ALBINO MOUSE; COMPARATIVE STUDY; CYTOCHEMISTRY; GENE VECTOR; GENETICS; HEART MUSCLE; IMMUNOLOGY; METABOLISM; SKELETAL MUSCLE;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; BETA-GALACTOSIDASE; FETUS; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HISTOCYTOCHEMISTRY; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; MYOCARDIUM; TRANSGENES;

EID: 3242734178     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.421     Document Type: Article

References (47)

1. Cho WK, Ebihara S, Nalbantoglu J, et al. Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route. Hum Gene Ther 2000; 11: 701-714.
2. O'Hara AJ, Howell JM, Taplin RH, et al. The spread of transgene expression at the site of gene construct injection. Muscle Nerve 2001; 24: 488-495.
3. Stedman HH. Molecular approaches to therapy for Duchenne and limb-girdle muscular dystrophy. Curr Opin Mol Ther 2001; 3: 350-356.
4. Braun S, Thioudellet C, Rodriguez P, et al. Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice. Gene Ther 2000; 7: 1447-1457.
5. Ferrer A, Wells KE, Wells DJ. Immune responses to dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Gene Ther 2000; 7: 1439-1446.
6. Reimann J, Irintchev A, Wernig A. Regenerative capacity and the number of satellite cells in soleus muscles of normal and mdx mice. Neuromuscul Disord 2000; 10: 276-282.
7. Flake AW, Zanjani ED. In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood 1999; 94: 2179-2191.
8. Prenatal gene transfer: scientific, medical, and ethical issues: a report of the Recombinant DNA Advisory Committee. Hum Gene Ther 2000; 11: 1211-1229.
9. Xiao W, Berta SC, Lu MM, Moscioni AD, Tazelaar J, Wilson JM. Adeno-associated virus as a vector for liver-directed gene therapy. J Virol 1998; 72: 10 222-10 226.
10. Chirmule N, Xiao W, Truneh A, et al. Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J Virol 2000; 74: 2420-2425.
11. Yang Y, Li Q, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995; 69: 2004-2015.
12. Hildinger M, Auricchio A, Gao G, Wang L, Chirmule N, Wilson JM. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J Virol 2001; 75: 6199-6203.
13. Kim HB, Shaaban AF, Milner R, Fichter C, Flake AW. In utero bone marrow transplantation induces tolerance by a combination of clonal deletion and anergy. J Pediatr Surg 1999; 34: 726-730.
14. Shaaban AF, Kim HB, Milner R, Flake AW. A kinetic model for homing and migration of prenatally transplanted marrow. Blood 1999; 94: 3251-3257.
15. Yang EY, Kim HB, Shaaban AF, Milner R, Adzick NS, Flake AW. Persistent postnatal transgene expression in both muscle and liver after fetal injection of recombinant adenovirus. J Pediatr Surg 1999; 34: 766-772.
16. Xiao W, Chirmule N, Berta SC, McCullough B, Gao G, Wilson JM. Gene therapy vectors based on adeno-associated virus type 1. J Virol 1999; 73: 3994-4003.
17. Hayashi S, Peranteau WH, Shaaban AF, Flake AW. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. Blood 2002; 100: 804-812.
18. Peranteau WF, Hayashi S, Hsieh M, Shaaban AF, Flake AW. High level allogeneic chimerism achieved by prenatal tolerance induction and postnatal non-myeloablative bone marrow transplantation. Blood 2002; 100: 2225-2234.
19. Lipshutz GS, Gruber CA, Cao Y, Hardy J, Contag CH, Gaensler KM. In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. Mol Ther 2001; 3 284-292.
20. Mitchell M, Jerebtsova M, Batshaw ML, Newman K, Ye X. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors. Gene Ther 2000; 7: 1986-1992.
21. Chao H, Liu Y, Rabinowitz J, Li C, Samulski RJ, Walsh CE. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2000; 2: 619-623.
22. Duan D, Yan Z, Yue Y, Ding W, Engelhardt JF. Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation. J Virol 2001; 75: 7662-7671.
23. Holzinger A, Trapnell BC, Weaver TE, Whitsett JA, Iwamoto HS. Intraamniotic administration of an adenoviral vector for gene transfer to fetal sheep and mouse tissues. Pediatr Res 1995; 38: 844-850.
24. Larson JE, Morrow SL, Happel L, Sharp JF, Cohen JC. Reversal of cystic fibrosis phenotype in mice by gene therapy in utero. Lancet 1997; 349: 619-620.
25. Larson JE, Morrow SL, Delcarpio JB, et al. Gene transfer into the fetal primate: evidence for the secretion of transgene product. Mol Ther 2000; 2: 631-639.
26. McCray PB Jr, Armstrong K, Zabner J, et al. Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J Clin Invest 1995; 95: 2620-2632.
27. Iwamoto HS, Trapnell BC, McConnell CJ, Daugherty C, Whitsett JA. Pulmonary inflammation associated with repeated, prenatal exposure to an E1,E3-deleted adenoviral vector in sheep. Gene Ther 1999; 6 98-106.
28. Sylvester KG, Yang EY, Cass DL, Crombleholme TM, Adzick NS. Fetoscopic gene therapy for congenital lung disease. J Pediatr Surg 1997; 32: 964-969.
29. Vincent MC, Trapnell BC, Baughman RP, Wert SE, Whitsett JA, Iwamoto HS. Adenovirus-mediated gene transfer to the respiratory tract of fetal sheep in utero. Hum Gene Ther 1995; 6: 1019-1028.
30. Turkay A, Saunders T, Kurachi K. Intrauterine gene transfer: gestational stage-specific gene delivery in mice. Gene Ther 1999; 6: 1685-1694.
31. Christensen G, Minamisawa S, Gruber PJ, Wang Y, Chien KR. High-efficiency, long-term cardiac expression of foreign genes in living mouse embryos and neonates. Circulation 2000; 101: 178-184.
32. Lipshutz GS, Flebbe-Rehwaldt L, Gaensler EM. Adenovirus-mediated gene transfer to the peritoneum and hepatic parenchyma of fetal mice in utero. Surgery 1999; 126: 171-177.
33. Lipshutz GS, Flebbe-Rehwaldt L, Gaensler KM. Adenovirus-mediated gene transfer in the midgestation fetal mouse. J Surg Res 1999; 84: 150-156.
34. Lipshutz GS, Sarkar R, Flebbe-Rehwaldt L, Kazazian H, Gaensler KM. Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero. Proc Natl Acad Sci U S A 1999; 96: 13 324-13 329.
35. Schneider H, Muhle C, Marie Douar A, et al. Sustained delivery of therapeutic concentrations of human clotting factor IX - a comparison of adenoviral and AAV vectors administered in utero. J Gene Med 2002; 4: 46-53.
36. Young SM Jr, McCarty DM, Degtyareva N, Samulski RJ. Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination. J Virol 2000; 74: 3953-3966.
37. Nakai H, Yant SR, Storm TA, Fuess S, Meuse L, Kay MA. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J Virol 2001; 75: 6969-6976.
38. Herweijer H, Zhang G, Subbotin VM, Budker V, Williams P, Wolff JA. Time course of gene expression after plasmid DNA gene transfer to the liver. J Gene Med 2001; 3: 280-291.
39. Chen SJ, Tazelaar J, Moscioni AD, Wilson JM. In vivo selection of hepatocytes transduced with adeno-associated viral vectors. Mol Ther 2000; 1: 414-422.
40. Manning K, Al-Dhalimy M, Finegold M, Grompe M. In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I. Proc Natl Acad Sci U S A 1999; 96: 11 928-11 933.
41. Woo YJ, Raju GP, Swain JL, Richmond ME, Gardner TJ, Balice-Gordon RJ. In utero cardiac gene transfer via intraplacental delivery of recombinant adenovirus. Circulation 1997; 96: 3561-3569.
42. Wassilev W, Wedel T, Michailova K, Kuhnel W. A scanning electron microscopy study of peritoneal stomata in different peritoneal regions. Anat Anz 1998; 180: 137-143.
43. Lipshutz GS, Flebbe-Rehwaldt L, Gaensler KM. Reexpression following readministration of an adenoviral vector in adult mice after initial in utero adenoviral administration. Mol Ther 2000; 2: 374-380.
44. Yang EY, Cass DL, Sylvester KG, Wilson JM, Adzick NS. BAPS Prize 1997. Fetal gene therapy: efficacy, toxicity, and immunologic effects of early gestation recombinant adenovirus. J Pediatr Surg 1999; 34: 235-241.
45. Tran ND, Porada CD, Almeida-Porada G, Glimp HA, Anderson WF, Zanjani ED. Induction of stable prenatal tolerance to beta-galactosidase by in utero gene transfer into preimmune sheep fetuses. Blood 2001; 97: 3417-3423.
46. DeMatteo RP, Chu G, Ahn M, Chang E, Barker CF, Markmann JF. Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression. J Virol 1997; 71: 5330-5335.
47. Mackenzie TC, Kobinger GP, Kootstra NA, et al. Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol Ther 2002; 6 349-358.